156P ASTRIS, a real-world study with osimertinib in patients with non-small cell lung cancer (NSCLC) EGFR T790M mutated: Characteristics and diagnostic methods used for patients included in Spain
Baz, D. Vicente, Lario, A. Paredes, Bueno, M.T. Moran, Sureda, B. Massuti, Reguard, N., Álvarez, R., Molla, A. Insa, Juan, O., Marquez, G., Pulla, M. ProvencioVolume:
13
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/S1556-0864(18)30430-1
Date:
April, 2018
File:
PDF, 91 KB
english, 2018